Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ILE

Isolagen (ILE)

Isolagen

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:ILE

1 2 3 4 5 6 7 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
06/10/2009	15h00	PR Newswire (US)	Isolagen, Inc. Reorganizes as Fibrocell Science, Inc.	AMEX:ILE
16/06/2009	23h52	PR Newswire (US)	Isolagen, Inc. Announces Filing of Voluntary Petition Under Chapter 11 of the Bankruptcy Code	AMEX:ILE
08/05/2009	15h00	PR Newswire (US)	Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review	AMEX:ILE
06/05/2009	21h18	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILE	Isolagen
06/05/2009	21h14	PR Newswire (US)	Isolagen Receives Bridge Financing to Allow it to Seek Debtor-in-Possession Financing in Connection With a Possible Filing Under	AMEX:ILE
06/05/2009	00h55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
30/04/2009	23h16	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	AMEX:ILE	Isolagen
29/04/2009	23h51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
22/04/2009	01h14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
15/04/2009	15h38	Edgar (US Regulatory)	Annual Report (10-K)	AMEX:ILE	Isolagen
09/04/2009	23h23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
06/04/2009	22h51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
01/04/2009	01h04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
31/03/2009	23h15	Edgar (US Regulatory)	Notification that Annual Report will be submitted late (NT 10-K)	AMEX:ILE	Isolagen
31/03/2009	01h45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
23/03/2009	22h17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
20/03/2009	22h06	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILE	Isolagen
20/03/2009	22h00	PR Newswire (US)	Isolagen, Inc. Receives Notification Letter from Amex	AMEX:ILE	Isolagen
18/03/2009	23h29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
11/03/2009	23h23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
09/03/2009	14h00	PR Newswire (US)	Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration	AMEX:ILE	Isolagen
06/03/2009	23h22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
05/03/2009	15h25	PR Newswire (US)	Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acn	AMEX:ILE	Isolagen
17/02/2009	19h47	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	AMEX:ILE	Isolagen
17/02/2009	19h36	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	AMEX:ILE	Isolagen
17/02/2009	16h28	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	AMEX:ILE	Isolagen
04/02/2009	15h20	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILE	Isolagen
03/12/2008	23h02	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILE	Isolagen
06/11/2008	23h27	Edgar (US Regulatory)	Quarterly Report (10-Q)	AMEX:ILE	Isolagen
23/10/2008	03h58	PR Newswire (US)	Isolagen, Inc. Provides Analysis of Data from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles	AMEX:ILE	Isolagen

Showing the most relevant articles for your search:AMEX:ILE

1 2 3 4 5 6 7 Next >>

NLBNPIT1Z364 20351219 31...

NLBNPIT1YJL9 20240621 30...

Leverage Shares 3x Short...

Energy Transfer

Banyan Acquisition

NLBNPIT1ZOX1 20241218 17...

Oat Fx 2.5% Sep27 Eur

Harmony French Home Loan...

European Investment Bank

Blue Ocean Acquisition

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen